Select Medical Holdings Corporation
SEM · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.49 | -0.42 | -0.02 | 0.30 |
| FCF Yield | 7.71% | 2.44% | -2.59% | 2.55% |
| EV / EBITDA | 21.26 | 34.79 | 30.51 | 76.01 |
| Quality | ||||
| ROIC | 1.16% | 1.42% | 1.76% | 0.56% |
| Gross Margin | 10.81% | 11.60% | 13.34% | 7.71% |
| Cash Conversion Ratio | 3.97 | 1.91 | -0.05 | 33.40 |
| Growth | ||||
| Revenue 3-Year CAGR | -15.79% | -12.60% | -12.59% | -9.41% |
| Free Cash Flow Growth | 167.95% | 181.74% | -189.99% | -52.41% |
| Safety | ||||
| Net Debt / EBITDA | 8.08 | 20.92 | 17.07 | 39.57 |
| Interest Coverage | 2.44 | 2.89 | 3.88 | -1.43 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 42.14 | 48.69 | 48.24 | 45.76 |